Skip to main content
Premium Trial:

Request an Annual Quote

NCI Extends Synthetic Genetics Agreement with GeneArt for $1.9M

NEW YORK (GenomeWeb News) – The National Cancer Institute has renewed a contract agreement with GeneArt, under which the company already has developed over 3,500 synthetic genes for around $3.5 million, the company said Friday.
GeneArt said it has agreed to develop another 200 genes for NCI’s Mammalian Gene Collection Program for an additional $1.9 million.
The contract the company initially agreed to in January 2007 was assigned by the company SAIC-Frederick on behalf of NCI and would allow it to perform up to $6.5 million in gene synthesis services for the institute.
The MGC Program is a collection of human and mouse genes to be used for basic research and for clinical R&D.
Due to a large number of repetitive DNA sequence elements and toxic elements involved in the research, GeneArt said it had to “further advance its existing technologies and establish new production techniques.”
The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.